Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
  • LinkedIn
  • Instagram
ReplyLetters

Response

Irfan A. Dhalla, Muhammad M. Mamdani, Tara Gomes and David N. Juurlink
Canadian Family Physician May 2011; 57 (5) 537-539;
Irfan A. Dhalla
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Muhammad M. Mamdani
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tara Gomes
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David N. Juurlink
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

The contrasting responses to our study illustrate that physicians hold widely divergent opinions regarding the prescribing of opioids for chronic noncancer pain. Sometimes, however, the opinions are so strident that the facts are overshadowed.

Here are some facts about opioids and chronic noncancer pain:

  1. The long-term use of opioids for chronic noncancer pain is supported by very little evidence; the evidence that does exist is of poor quality.1

  2. Almost all trials span less than 4 months and include only very carefully selected patients.1

  3. The few available observational studies suggest that the long-term risks of opioids in real-world clinical practice might exceed the benefits.2,3

  4. Despite a lack of evidence, opioid prescribing for chronic noncancer pain has increased dramatically over the past 20 years, as have the number of deaths involving prescription opioids.4,5

  5. Most opioid-related deaths are accidental and occur in relatively young people who have also consumed alcohol or other central nervous system depressants.4–6

  6. Most opioid-related deaths occur in individuals who have been prescribed opioids.4,7

Having stated these facts—all of which are repeatedly downplayed by pharmaceutical companies and the physicians with financial ties to them—we turn to the comments on our article.

Longhurst8 ascribes to us political motives, but does not specify what these might be. As clinicians and researchers with an interest in patient safety, our motivation is the promotion of safe prescribing, with the ultimate goal of better outcomes for patients. Regrettably, several of Longhurst’s comments suggest that he did not read our paper carefully. For example, we clearly stated that we analyzed publicly funded prescription claims and we did not assert that physicians had “caused death” or that “opiates are bad.”

As noted above, we agree with White9 that opioid-related deaths are typically associated with the use of alcohol or other central nervous system depressants. We also agree that the risk of mortality increases with opioid dose.7,10,11 But 3 important points remain. First, patients frequently receive opioids at doses far in excess of those recommended in clinical practice guidelines.12–14 Second, the mortality risk is elevated even at seemingly moderate doses (ie, 50 to 100 mg of morphine per day, and possibly even 20 to 50 mg of morphine per day).7,10 Third, opioids are associated with increased mortality when compared with nonsteroidal anti-inflammatory drugs.2

We agree with Dubin15 that education and licensure requirements ought to be improved and that pain management should be holistic. Although physicians are remunerated by provincial health insurance plans for counseling, they are paid more for short, frequent visits—encounters that, in the context of pain, often culminate in a prescription. This financial inequity should be addressed. Of course, we also agree with Dubin that correlation is not synonymous with causation, and we were careful not to assert causality in our article. Nevertheless, the totality of evidence does indeed suggest that increased opioid prescribing has resulted in an epidemic of opioid-related deaths in North America.

In their protracted defense of chronic opioid therapy, Jovey et al16 falsely assert that we confuse association with causation. They also imply that a large proportion of opioid-related deaths are suicides. This is wrong. As we and others have noted, most opioid-related deaths are accidents.4,5 Furthermore, accidental opioid-related deaths have increased dramatically, while the number of suicides involving opioids has remained static.4 It is difficult to overstate the importance of this observation.

Jovey et al16 suggest that other substances (eg, benzodiazepines and alcohol) might be responsible for death, rather than opioids themselves. These and other co-intoxicants are best characterized as contributing factors. Although they are commonly identified in the postmortem toxicology of patients with opioid-related deaths, their presence does little to exonerate the opioid. Most physicians will appreciate that deaths resulting solely from acute alcohol intoxication or acute benzodiazepine overdose are very rare, whereas deaths due solely to opioid intoxication are common by comparison. In a sample of 239 single-drug deaths in Virginia, 166 were due to opioids alone, compared with fewer than 5 from benzodiazepines alone.6 Consequently, when death occurs in an individual who has consumed opioids along with 1 or more other central nervous system depressants, it is entirely appropriate to focus on the opioid.

Jovey et al16 also assert that the inadvertent inclusion of palliative care physicians might explain our study’s findings. This too is wrong. Because deaths occurring among patients receiving palliative care are generally not investigated by coroners, the inclusion of physicians who prescribe opioids for palliative care would actually diminish any observed association between opioid prescribing frequency and opioid-related deaths.

We disagree with Jovey et al16 that the “death rate per prescription” is a useful metric. While both the number of opioid-related deaths and the number of opioid prescriptions have increased over time, the “death rate per prescription” has actually decreased. The explanation for this is simple—most patients receive more than 1 prescription yet each individual can obviously die only once. In any case, the absolute number of deaths is obviously far more important than the “death rate per prescription.”

In support of her assertion that “opioids exhibit efficacy in some people with chronic pain,” Lynch17 cites a Cochrane review that did not include a single randomized controlled trial comparing opioids with other therapies. Why? Because, as the authors of the review note, the published trials were too short to merit inclusion in the review.

The lack of evidence for long-term opioid use is both lamentable and unjustifiable. Such a paucity of safety and effectiveness data would never be sufficient to inform the care of patients with coronary artery disease or cancer. Why has no high-quality evidence been produced to support the long-term use of opioids in patients with chronic noncancer pain? One reason might be that many pain specialists—particularly those who are vocal advocates for chronic opioid therapy—receive large amounts of money from pharmaceutical companies that manufacture opioids. These “thought leaders” have little incentive to press pharmaceutical companies to improve the evidence base for chronic opioid therapy. Even the Canadian Pain Society, of which Lynch is the current president, has received considerable funding from opioid manufacturers over the past 20 years. As Ballantyne has recently noted, “It has been the drug companies that have for years picked the message and the messengers while sponsoring much of the postgraduate education and all the major pain meetings.”18

We appreciate the letters of Pakes19 and Kahan.20 We would emphasize Pakes’ point that opioid prescribing is an important ethical issue for physicians, and Kahan’s point that most physicians who prescribe opioids frequently or at high doses are well intentioned, but have been unwittingly influenced or misled by the promotional tactics of the pharmaceutical industry.

We agree with Shulman21 and Fulton22 that physicians should “sit on the same side of the desk” as their patients when discussing opioids. But we also believe that physicians should consider the modified Hippocratic Oath, which states that physicians “will apply, for the benefit of the sick, all measures [that] are required, avoiding those twin traps of overtreatment and therapeutic nihilism.”23

In the present-day treatment of chronic noncancer pain, the pendulum has swung too far toward over-treatment, placing huge numbers of patients at risk of addiction and death. Until there is better evidence that the benefits of long-term opioids justify these risks, we should all reevaluate our prescribing of opioids for patients with chronic noncancer pain.

Footnotes

  • Competing interests

    None declared

  • Copyright© the College of Family Physicians of Canada

References

  1. ↵
    1. Chou R,
    2. Ballantyne JC,
    3. Fanciullo GJ,
    4. Fine PG,
    5. Miaskowski C
    . Research gaps on use of opioids for chronic noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009;10(2):147-59.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Solomon DH,
    2. Rassen JA,
    3. Glynn RJ,
    4. Lee J,
    5. Levin R,
    6. Schneeweiss S
    . The comparative safety of analgesics in older adults with arthritis. Arch Intern Med 2010;170(22):1968-76.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Sjogren P,
    2. Gronbaek M,
    3. Peuckmann V,
    4. Ekholm O
    . A population-based cohort study on chronic pain: the role of opioids. Clin J Pain 2010;26(9):763-9.
    OpenUrlPubMed
  4. ↵
    1. Dhalla IA,
    2. Mamdani MM,
    3. Sivilotti ML,
    4. Kopp A,
    5. Qureshi O,
    6. Juurlink DN
    . Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ 2009;181(12):891-6. Epub 2009 Dec 7.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Warner M,
    2. Chen LH,
    3. Makuc DM
    . Increase in fatal poisonings involving opioid analgesics in the United States, 1999–2006. Atlanta, GA: National Center for Health Statistics; 2009. NCHS data brief no. 22. Available from: www.cdc.gov/nchs/data/data-briefs/db22.pdf. Accessed 2011 Apr 7.
  6. ↵
    1. Substance Abuse and Mental Health Services Administration, Office of Applied Studies
    . Drug abuse warning network, 2008: area profiles of drug-related mortality. Rockville, MD: US Department of Health and Human Services; 2010. Available from: https://dawn-info.samhsa.gov/files/ME2008/ME08_Complete.pdf. Accessed: 2011 Apr 7.
  7. ↵
    1. Bohnert AS,
    2. Valenstein M,
    3. Bair MJ,
    4. Ganoczy D,
    5. McCarthy JF,
    6. Ilgen MA,
    7. et al
    . Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011;305(13):1315-21.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Longhurst CP
    . Disappointing study [Rapid Response]. Can Fam Physician 2011 Mar 15. Available from: www.cfp.ca/content/57/3/e92/reply#cfp_el_2253. Accessed 2011 Apr 8.
  9. ↵
    1. White MI
    . Misleading conclusions [Letters]. Can Fam Physician 2011;57:530.
    OpenUrlFREE Full Text
  10. ↵
    1. Gomes T,
    2. Juurlink DN,
    3. Dhalla IA,
    4. Paterson JM,
    5. Mamdani MM
    . Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med 2011;171(7):686-93.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Dunn KM,
    2. Saunders KW,
    3. Rutter CM,
    4. Banta-Green CJ,
    5. Merrill JO,
    6. Sullivan MD,
    7. et al
    . Opioid prescriptions for chronic pain and overdose. Ann Intern Med 2010;152(2):85-92.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Mailis-Gagnon A,
    2. Lakha SF,
    3. Ou T,
    4. Louffat A,
    5. Yegneswaran B,
    6. Umana M,
    7. et al
    . Chronic noncancer pain. Characteristics of patients prescribed opioids by community physicians and referred to a tertiary pain clinic. Can Fam Physician. Vol. 57. 2011. p. e97-105. Available from: www.cfp.ca/content/57/3/e97.full.pdf+html. Accessed 2011 Apr 7.
    OpenUrlAbstract/FREE Full Text
    1. Morasco BJ,
    2. Duckart JP,
    3. Carr TP,
    4. Deyo RA,
    5. Dobscha SK
    . Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain. Pain 2010;151(3):625-32.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Gomes T,
    2. Juurlink DN,
    3. Dhalla IA,
    4. Mailis-Gagnon A,
    5. Paterson JM,
    6. Mamdani MM
    . Trends in opioid use and dosing among socio-economically disadvantaged patients. Open Med 2011;5(1):E13-22. Available from: www.openmedicine.ca/article/view/421. Accessed 2011 Apr 7.
    OpenUrlPubMed
  14. ↵
    1. Dubin R
    . Mind the gap [Letters]. Can Fam Physician 2011;57:530-1.
    OpenUrlFREE Full Text
  15. ↵
    1. Jovey RD,
    2. Squire P,
    3. Williamson OD
    . Treating patients versus numbers [Letters]. Can Fam Physician 2011;57:532-5.
    OpenUrlFREE Full Text
  16. ↵
    1. Lynch ME
    . Clustering of opioid prescribing—what is really going on? [Letters]. Can Fam Physician 2011;57:535-6.
    OpenUrlFREE Full Text
  17. ↵
    1. Ballantyne JC
    . Pain medicine: repairing a fractured dream. Anesthesiology 2011;114(2):243-6.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Pakes BN
    . Opioid prescribing—a matter of ethics [Letters]. Can Fam Physician 2011;57:531-2.
    OpenUrlFREE Full Text
  19. ↵
    1. Kahan MM
    . The opioid crisis in North America [Letters]. Can Fam Physician 2011;57:536.
    OpenUrlFREE Full Text
  20. ↵
    1. Shulman DL
    . We can’t feel their pain, but we can understand their fears [Letters]. Can Fam Physician 2011;57:536-7.
    OpenUrlFREE Full Text
  21. ↵
    1. Fulton J
    . Opioids pain and personality. The story of a substitute physician. Can Fam Physician 2011;57:271, 272. (Eng),. (Fr).
    OpenUrlFREE Full Text
  22. ↵
    1. Lasagna L
    . The Hippocratic Oath: modern version. Arlington, PA: Public Broadcasting Service; 1964. Available from: www.pbs.org/wgbh/nova/doctors/oath_modern.html. Accessed 2011 Apr 7.
PreviousNext
Back to top

In this issue

Canadian Family Physician: 57 (5)
Canadian Family Physician
Vol. 57, Issue 5
1 May 2011
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Response
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Response
Irfan A. Dhalla, Muhammad M. Mamdani, Tara Gomes, David N. Juurlink
Canadian Family Physician May 2011, 57 (5) 537-539;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Response
Irfan A. Dhalla, Muhammad M. Mamdani, Tara Gomes, David N. Juurlink
Canadian Family Physician May 2011, 57 (5) 537-539;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • References
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • The real crisis of chronic pain
  • Google Scholar

More in this TOC Section

  • Collaboration required to fix “hidden curriculum”
  • Correction
  • Long-term monitoring needed for lichen sclerosus
Show more Letters

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • LinkedIn
  • Instagram
  • RSS Feeds

Copyright © 2025 by The College of Family Physicians of Canada

Powered by HighWire